☰

Ronda R. Bransteitter, Ph.D. - Publications

Affiliations: 
2005 University of Southern California, Los Angeles, CA, United States 
Area:
Immunology, Molecular Biology
Tree Info Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Schmitt K, Guo K, Katuwal M, Wilson D, Prochnow C, Bransteitter R, Chen XS, Santiago ML, Stephens EB. Lentivirus restriction by diverse primate APOBEC3A proteins. Virology. 442: 82-96. PMID 23648232 DOI: 10.1016/J.Virol.2013.04.002  0.481
2009 Prochnow C, Bransteitter R, Chen XS. APOBEC deaminases-mutases with defensive roles for immunity. Science in China. Series C, Life Sciences / Chinese Academy of Sciences. 52: 893-902. PMID 19911124 DOI: 10.1007/S11427-009-0133-1  0.551
2009 Bransteitter R, Prochnow C, Chen XS. The current structural and functional understanding of APOBEC deaminases. Cellular and Molecular Life Sciences : Cmls. 66: 3137-47. PMID 19547914 DOI: 10.1007/S00018-009-0070-Y  0.481
2009 Prochnow C, Bransteitter R, Goodman MF, Chen XS. The prospect of APOBEC3G for the future of HIV therapy Hiv Therapy. 3: 7-10. DOI: 10.2217/17584310.3.1.7  0.487
2008 Holden LG, Prochnow C, Chang YP, Bransteitter R, Chelico L, Sen U, Stevens RC, Goodman MF, Chen XS. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications. Nature. 456: 121-4. PMID 18849968 DOI: 10.1038/Nature07357  0.612
2007 Prochnow C, Bransteitter R, Klein MG, Goodman MF, Chen XS. The APOBEC-2 crystal structure and functional implications for the deaminase AID. Nature. 445: 447-51. PMID 17187054 DOI: 10.1038/Nature05492  0.65
2006 Bransteitter R, Sneeden JL, Allen S, Pham P, Goodman MF. First AID (activation-induced cytidine deaminase) is needed to produce high affinity isotype-switched antibodies. The Journal of Biological Chemistry. 281: 16833-6. PMID 16624806 DOI: 10.1074/Jbc.R600006200  0.598
2005 Pham P, Bransteitter R, Goodman MF. Reward versus risk: DNA cytidine deaminases triggering immunity and disease. Biochemistry. 44: 2703-15. PMID 15723516 DOI: 10.1021/Bi047481+  0.625
2005 Larijani M, Frieder D, Sonbuchner TM, Bransteitter R, Goodman MF, Bouhassira EE, Scharff MD, Martin A. Methylation protects cytidines from AID-mediated deamination. Molecular Immunology. 42: 599-604. PMID 15607819 DOI: 10.1016/J.Molimm.2004.09.007  0.552
2004 Tippin B, Pham P, Bransteitter R, Goodman MF. Somatic hypermutation: a mutational panacea. Advances in Protein Chemistry. 69: 307-35. PMID 15588848 DOI: 10.1016/S0065-3233(04)69011-5  0.613
2004 Bransteitter R, Pham P, Calabrese P, Goodman MF. Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase. The Journal of Biological Chemistry. 279: 51612-21. PMID 15371439 DOI: 10.1074/Jbc.M408135200  0.58
2003 Pham P, Bransteitter R, Petruska J, Goodman MF. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature. 424: 103-7. PMID 12819663 DOI: 10.1038/Nature01760  0.607
2003 Bransteitter R, Pham P, Scharff MD, Goodman MF. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proceedings of the National Academy of Sciences of the United States of America. 100: 4102-7. PMID 12651944 DOI: 10.1073/Pnas.0730835100  0.57
Show low-probability matches.